Wells, Athol U.
Denton, Christopher P.
Article History
First Online: 30 September 2014
Competing interests
: A.U.W. declares the following competing interests: consultancy fees from Boehringer Ingelheim, Genentech, Gilead, Intermune, MedImmune, Takeda; and honoraria from Actelion Pharmaceuticals, Beohringer Ingelheim and Intermune. C.P.D. declares that he has received consultancy fees, honoraria and research funding from Actelion Pharmaceuticals, and consultancy fees and honoraria from GlaxoSmithKline, Merck-Serono, Novartis, Pfizer and Sanofi-Aventis.